The pursuit of human longevity, it seems, has just acquired a decidedly long-term investment strategy: cryonics. While most might consider post-mortem planning to involve little more than property and personal effects, a select few are opting for the ultimate in future-proofing – the preservation of their bodies and brains after death, a choice highlighted by the case of gerontologist L. Stephen Coles MIT Tech Review.
The Ultimate Niche Market
This isn't your average market trend, nor is it driven by government mandate or central planning. Instead, cryonics represents a fascinating, albeit unconventional, response to individual demand for potential future revival. It’s a testament to the market's capacity to cater to even the most esoteric desires, demonstrating that where there is a will — or perhaps, a wish for a will in the future — a service will likely emerge to facilitate it.
L. Stephen Coles, a gerontologist who devoted the latter part of his career to human longevity, chose to have his brain preserved following his death from pancreatic cancer in 2014 MIT Tech Review. His decision, and those of others, underpins the market for cryonic storage, pushing the boundaries of what is considered a 'service' in the free market. It underscores a fundamental principle: if individuals are willing to pay for a particular service, and others are capable and willing to provide it, then the market, in its infinite wisdom and occasional peculiarity, will find a way.
The Mechanics of Individual Choice
Unlike an ATM which, contrary to popular belief, didn't eliminate bank tellers but rather made branches more efficient and numerous, cryonics isn't aiming to optimize current human processes. Instead, it’s a speculative bet on future technological advancement, driven by a deeply personal belief in overcoming biological limits. It is a market that operates on a highly individualistic premise, where consumers are quite literally investing in their own hypothetical second act.
This is not a system for the faint of heart, nor for those who prefer their investments to mature in a more conventional timeframe. It exists because individuals, exercising their fundamental freedom, choose to engage with it, and private entities are formed to meet that demand. The alternative – a government-run cryonics program – would undoubtedly entail endless committees, stifling regulations, and probably a budget deficit large enough to freeze a small moon, and all without the entrepreneurial drive that makes such niche services even possible.
Industry Impact and Future Outlook
The 'industry impact' of cryonics, while limited in scale compared to, say, the global semiconductor market, is significant in its symbolic value. It highlights the frontier spirit of private enterprise, willing to explore the edges of human possibility without requiring explicit permission from a governing body. These providers are not waiting for a regulatory framework to tell them how to handle the ultimate long-term care package; they are innovating in response to the individual's desire to defy the finality of death.
What comes next for cryonics is less about scientific breakthroughs – though those would certainly help – and more about the ongoing exercise of individual choice. As long as some individuals remain convinced that technological progress will eventually make revival possible, and as long as others are willing to offer the intricate, decidedly cold storage solutions required, this unique corner of the market will persist. It reminds us that innovation often springs from the desire to solve unconventional problems, and sometimes, the problem is simply the end of life itself. Expect more, not less, of humanity's quirky bids for immortality, as long as the market remains free enough to facilitate them. After all, the cost of asking permission tends to be far higher than the cost of just doing it, especially when 'it' involves waiting for the future to catch up to your present-day ambitions.